Vaccine ‘may be able to delay relapse in specific pancreatic and bowel cancers’

Scientists found the vaccine successfully mobilised a substantial number of T cells from the body’s immune system. Picture: David Davies/PA

A new vaccine has shown “promising” signs of being able to prevent relapse of specific types of pancreatic and bowel cancers for people who have previously had surgery.

Avoiding relapse could also help increase rates of survival, researchers say.